TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
QGEN

Qiagen NV

Healthcare · Diagnostics & Research

44.20$ -0.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Qiagen NV (QGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 201 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow QGEN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
125 151 133 167 182 192 140 161 165 188 101 201 654
51 52 54 53 50 46 44 49 52 49 51 51 203
13 12 14 10 8.9 11 12 11 11 17 9.7 7.0 44
17 – – – – – – – – – – – –
-29 -41 -18 106 17 31 -15 -4.1 -26 11 -42 39 -19
41 52 38 39 44 50 44 41 46 71 47 43 207
248 -58 6.4 -18 -231 -6.8 120 -42 -157 -226 211 -70 -242
– – – – – – – – 54 0.0 – – –
-4.7 -0.5 -292 -27 -6.2 -0.9 -280 -10 -9.3 -2.7 -497 – –
-437 – – – 496 -502 – – 684 -476 – – –
-401 -7.4 -292 -127 486 -489 -287 -28 614 -478 -504 -8.5 -376
-30 88 -154 20 439 -309 -25 95 622 -517 -193 122 35
84 99 95 128 138 142 96 121 119 117 54 158 448

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?